Evidence map›Paper›PMID 41489039›Full record

ReviewAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Modulating Integrin and Growth Factor Signaling With Peptides: Strategies to Synergistically Enhance Bone Tissue Regeneration.

Lluís Oliver-Cervelló, Elisabetta Ada Cavalcanti-Adam, Carlos Mas-Moruno

Abstract readReview
In one paragraph

Review in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lluís Oliver-CervellóBiomaterials, Biomechanics and Tissue Engineering Group, Department of Materials Science and Engineering, and Institute for Research and Innovation in Health (IRIS), Universitat Politècnica de Catalunya, Barcelona, Spain.
Elisabetta Ada Cavalcanti-AdamCellular Biomechanics, University of Bayreuth, Bayreuth, Germany.
Carlos Mas-MorunoBiomaterials, Biomechanics and Tissue Engineering Group, Department of Materials Science and Engineering, and Institute for Research and Innovation in Health (IRIS), Universitat Politècnica de Catalunya, Barcelona, Spain.ORCID https://orcid.org/0000-0001-8337-0872

Funding

Agencia Estatal de Investigación CEX2023-001300-MAgencia Estatal de Investigación PID2023-148538OB-I00Generalitat de CatalunyaHorizon 2020 Framework Programme 872869
6 · The paper itself

Abstract

Providing biomaterials with cell-instructive cues represents a major goal in tissue engineering to tailor cell-material interactions and guide tissue regeneration. For bone tissue regeneration, this has been classically addressed by integrating integrin-binding proteins and peptides on different substrates, aiming at mimicking the bone extracellular matrix. However, it has become evident that integrin signaling alone is not sufficient to fully recreate the cellular microenvironment required to effectively drive bone healing, and that growth factors (GFs), such as bone morphogenetic proteins (BMPs), are essential for bone development and growth. Indeed, recent research has demonstrated that integrins engage in synergistic signaling with GF receptors (GFRs). For instance, it is now well established that the osteogenic activity of BMPs can be regulated, and often enhanced, by integrins. These findings have thus encouraged the study of novel multifunctional systems that combine integrin-binding ligands with osteoinductive cues to exploit integrin-GF crosstalk and regenerate bone. This review aims to provide a comprehensive overview of the different mechanisms of signaling between integrins and GFRs, and the existing strategies to harness synergistic effects. A particular focus is put on the recent developments using the well-known integrin-binding RGD peptide and its co-presentation with BMP-derived peptides.

Indexed as

Bone RegenerationIntegrinsIntercellular Signaling Peptides and ProteinsPeptidesSignal TransductionAnimalsBone Morphogenetic ProteinsHumansOsteogenesisTissue EngineeringBone Morphogenetic ProteinsIntegrinsIntercellular Signaling Peptides and ProteinsPeptidesBMPgrowth factorintegrinRGDsynergy

Identifiers

PMID41489039
PMCPMC13088351

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.